Latest On Inovio Pharmaceuticals, Inc (INO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-24 03:50 EST | News | Inovio wins orphan drug status for HPV-related candidate in Europe | N/A |  |
| 2023-05-18 07:17 EST | News | Inovio Pharmaceuticals, Inc. (INO) 2023 RBC Capital Markets Global Healthcare Conference (Transcript) | N/A | |
| 2023-05-17 18:36 EST | News | Inovio Corporate Presentation | N/A | |
| 2023-05-11 06:41 EST | News | Inovio Pharmaceuticals, Inc. (INO) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-10 17:08 EST | News | Inovio Pharmaceuticals GAAP EPS of -$0.16 misses by $0.02, revenue of $0.11M misses by $0.17M | N/A | |
| 2023-05-10 04:00 EST | News | Inovio Pharmaceuticals Q1 2023 Earnings Preview | N/A | |
| 2023-04-26 18:55 EST | News | Inovio's respiratory disorder therapy on way to get orphan drug status in EU | N/A | |
| 2023-04-17 22:45 EST | News | Inovio gains on Phase 1 data for Ebola booster shot | N/A | |
| 2023-04-04 16:10 EST | News | Inovio: Adrift At A Bargain Price But No Near-Term Catalyst | N/A | |
| 2023-03-14 06:00 EST | News | Inovio Pharmaceuticals, Inc. (INO) Oppenheimer 33rd Annual Healthcare Conference (Transcript) | N/A | |
| 2023-03-02 17:57 EST | News | Inovio stock rises amid mixed trial results for cervical lesions drug; Q4 clinical updates | N/A | |
| 2023-03-02 03:13 EST | News | Inovio Pharmaceuticals GAAP EPS of -$1.17 misses by $0.06, revenue of $10.26M misses by $0.29M | N/A | |
| 2023-03-02 03:13 EST | News | Inovio Pharmaceuticals, Inc. (INO) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-28 21:36 EST | News | Inovio Pharmaceuticals FY 2022 Earnings Preview | N/A | |
| 2023-01-31 16:52 EST | News | Inovio in strategic reorganization; 11% headcount reduction | N/A | |
| 2023-01-10 08:57 EST | News | Inovio: Hold For Future DNA Plasmid Therapy Progress | N/A | |
| 2022-11-17 22:53 EST | News | Inovio ends development of candidates for Lassa fever and Middle East Respiratory Syndrome | N/A | |
| 2022-11-10 01:41 EST | News | Inovio Pharmaceuticals stock rises on Q3 profit beat, raised cash runway guidance | N/A | |
| 2022-11-09 07:26 EST | News | Inovio Pharmaceuticals GAAP EPS of -$0.15 beats by $0.15, revenue of $9.15M | N/A | |
| 2022-11-09 07:25 EST | News | Inovio Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-09 07:25 EST | News | Inovio Pharmaceuticals, Inc. (INO) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-07 20:30 EST | News | Inovio Pharmaceuticals Q3 2022 Earnings Preview | N/A | |
| 2022-10-28 02:30 EST | News | Inovio Pharmaceuticals stops development of COVID-19 booster shot candidate | N/A | |
| 2022-10-24 23:11 EST | News | Inovio Pharmaceuticals: Catalysts On The Horizon | N/A | |
| 2022-10-13 12:26 EST | News | Inovio reports positive phase 1/2 results for recurrent respiratory papillomatosis drug | N/A | |
| 2022-09-27 12:45 EST | News | Inovio Pharmaceuticals: Long On Promise, Short On Results | N/A | |
| 2022-09-12 19:28 EST | News | Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 24th Annual Global Investment Conference (Transcript) | N/A | |
| 2022-08-10 01:47 EST | News | Inovio Pharmaceuticals GAAP EPS of -$0.46 misses by $0.15, revenue of $0.78M beats by $0.26M | N/A | |
| 2022-08-10 01:47 EST | News | Inovio beats on the top line but misses on the bottom; quarterly net loss widens 32% | N/A | |
| 2022-08-10 01:46 EST | News | Inovio Pharmaceuticals, Inc. (INO) CEO Jacqueline Shea on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 03:59 EST | News | Inovio Pharmaceuticals Q2 2022 Earnings Preview | N/A | |
| 2022-07-19 18:54 EST | News | Inovio to cut workforce by 18% as part of corporate reorganization | N/A | |
| 2022-07-19 18:54 EST | News | Inovio Pharmaceuticals slotted at Sector Perform by RBC Capital in initial rating look | N/A | |
| 2022-07-19 04:14 EST | News | Inovio: After All These Years | N/A | |
| 2022-06-27 10:13 EST | News | INOVIO appoints Dr. Michael Sumner as CMO | N/A | |
| 2022-06-08 20:43 EST | News | Inovio Pharmaceuticals, Inc. (INO) CEO Jacqui Shea Present at Jefferies 2022 Global Healthcare Conference (Transcript) | N/A | |
| 2022-05-27 21:55 EST | News | Inovio announces positive survival results from trial testing glioblastoma treatment | N/A | |
| 2022-05-12 00:50 EST | News | Inovio downgraded at Oppenheimer as CEO departure adds uncertainty | N/A | |
| 2022-05-11 05:04 EST | News | Jacqueline Shea named new CEO of Inovio | N/A | |
| 2022-05-11 05:04 EST | News | Inovio Pharmaceuticals Non-GAAP EPS of -$0.36, revenue of $0.2M | N/A | |
| 2022-05-11 05:04 EST | News | Inovio Pharmaceuticals falls 20% on Q1 misses, announcement of new CEO | N/A | |
| 2022-05-11 05:04 EST | News | Inovio Pharmaceuticals, Inc. (INO) on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 07:30 EST | News | Inovio Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-04-15 14:34 EST | News | Inovio: Long-Term Biotech To Own With Several Catalysts Expected In 2022 | N/A | |
| 2022-03-16 03:16 EST | News | Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Oppenheimer's 32nd Annual Healthcare Conference (Transcript) | N/A | |
| 2022-03-02 18:57 EST | News | Inovio Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-03-02 18:57 EST | News | Inovio COVID vaccine weaker vs Omicron in lab test; phase 3 trial enrollment paused | N/A | |
| 2022-03-02 02:32 EST | News | Inovio Pharmaceuticals GAAP EPS of -$1.45 misses by $0.19, revenue of $1.77M beats by $0.31M | N/A | |
| 2022-03-02 02:32 EST | News | Inovio Pharmaceuticals results miss on the bottom line; shares down 9% | N/A | |
| 2022-03-02 02:31 EST | News | Inovio Pharmaceuticals, Inc. (INO) CEO Dr. Joseph Kim on Q4 2021 Results - Earnings Call Transcript | N/A | |
About Inovio Pharmaceuticals, Inc (INO):
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon optimized plasmids that have ability to help break the immune system's tolerance of cancerous or infected cells and facilitate cross-strain protection against unmatched and matched pathogen variants. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company also has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800, which is currently in Phase I clinical testing for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquart
General
- Name Inovio Pharmaceuticals, Inc
- Symbol INO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 262
- Last Split Factor1:4
- Last Split Date2014-06-06
- Fiscal Year EndDecember
- IPO Date1998-02-12
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.inovio.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 221.24
- Price/Book (Most Recent Quarter) 4.76
- Enterprise Value Revenue 245.85
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.59
- Next Year EPS Estimate $0.25
- Next Quarter EPS Estimate -$0.18
- Operating Margin -1674%
- Return on Assets -23%
- Return on Equity -72%
- Revenue 7.41 million
- Earnings Per Share -$1.22
- Revenue Per Share $0.05
- Gross Profit -86834216
- Quarterly Earnings Growth 1896.7%
View More
Highlights
- Market Capitalization 2.15 billion
- EBITDA -108041976
- PE Ratio -1.54
- Analyst Target Price $16
- Book Value Per Share $2.47
View More
Share Statistics
- Shares Outstanding 207.63 million
- Shares Float 204.08 million
- % Held by Insiders 217%
- % Held by Institutions 36.49%
- Shares Short 50.23 million
- Shares Short Prior Month 43.09 million
- Short Ratio 2.19
- Short % of Float 25%
- Short % of Shares Outstanding 24%
View More
Technicals
- Beta 0.97
- 52 Week High $33.79
- 52 Week Low $6.5
- 50 Day Moving Average 12.08
- 200 Day Moving Average 11.47
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Inovio Pharmaceuticals, Inc (INO) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Inovio Pharmaceuticals, Inc (INO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-01 | $N/A | -$0.11 | -$0.22 | 50.85% |
| 2020-09-30 | 2020-11-09 | $N/A | $0.11 | -$0.19 | 158.26% |
| 2020-06-30 | 2020-08-10 | $N/A | -$0.83 | -$0.17 | -391.71% |
| 2020-03-31 | 2020-05-11 | $1.33 million | -$0.26 | -$0.23 | -15.56% |
| 2019-12-31 | 2020-03-12 | $279488 | -$0.38 | -$0.24 | -59.26% |
| 2019-09-30 | 2019-11-12 | $866863 | -$0.23 | -$0.25 | 7.37% |
| 2019-06-30 | 2019-08-08 | $135673 | -$0.30 | -$0.28 | -6.04% |
| 2019-03-31 | 2019-05-09 | $2.83 million | -$0.30 | -$0.26 | -15.38% |
| 2018-12-31 | 2019-03-12 | $2.5 million | -$0.34 | -$0.29 | -15.65% |
| 2018-09-30 | 2018-11-08 | $2 million | -$0.27 | -$0.31 | 13.46% |
| 2018-06-30 | 2018-08-07 | $24.45 million | -$0.07 | -$0.27 | 73.58% |
| 2018-03-31 | 2018-05-09 | $1.53 million | -$0.36 | -$0.08 | -350% |
| 2017-12-31 | 2018-03-14 | $8.79 million | -$0.23 | -$0.30 | 22.48% |
| 2017-09-30 | 2017-11-08 | $2.65 million | -$0.39 | -$0.26 | -52.94% |
| 2017-06-30 | 2017-08-08 | $20.41 million | -$0.13 | -$0.19 | 32.29% |
| 2017-03-31 | 2017-05-10 | $10.38 million | -$0.31 | -$0.31 | 0.8% |
| 2016-12-31 | 2017-03-15 | $8.51 million | -$0.35 | -$0.33 | -7.69% |
| 2016-09-30 | 2016-11-09 | $12.54 million | -$0.28 | -$0.27 | -4.48% |
| 2016-06-30 | 2016-08-08 | $6.2 million | -$0.26 | -$0.21 | -26.21% |
| 2016-03-31 | 2016-05-09 | $8.11 million | -$0.11 | -$0.23 | 52.17% |
| 2015-12-31 | 2016-03-14 | $5.94 million | -$0.25 | -$0.21 | -21.95% |
| 2015-09-30 | 2015-11-09 | $24.18 million | $0.07 | $0.04 | 75% |
| 2015-06-30 | 2015-08-10 | $5.29 million | -$0.09 | -$0.13 | 30.77% |
| 2015-03-31 | 2015-05-11 | $5.17 million | -$0.17 | -$0.11 | -54.55% |
| 2014-12-31 | 2015-03-16 | $2.46 million | -$0.12 | -$0.10 | -20% |
| 2014-09-30 | 2014-11-10 | $1.84 million | -$0.12 | -$0.14 | 14.29% |
| 2014-06-30 | 2014-08-11 | $3.8 million | -$0.18 | -$0.19 | 5.26% |
| 2014-03-31 | 2014-05-12 | $2.36 million | -$0.20 | -$0.16 | -25% |
| 2013-12-31 | 2014-03-17 | $1.74 million | -$0.28 | -$0.14 | -100% |
| 2013-09-30 | 2013-11-12 | $9.49 million | -$0.64 | -$0.10 | -540% |
| 2013-06-30 | 2013-08-09 | $786000 | -$0.24 | -$0.14 | -71.43% |
| 2013-03-31 | 2013-05-10 | $1.46 million | -$0.24 | -$0.17 | -41.18% |
| 2012-12-31 | 2013-03-18 | $1.14 million | -$0.02 | -$0.18 | 89.61% |
| 2012-09-30 | 2012-11-07 | $855000 | -$0.20 | -$0.14 | -42.86% |
| 2012-06-30 | 2012-08-09 | $436000 | -$0.12 | -$0.17 | 29.41% |
| 2012-03-31 | 2012-05-09 | $1.69 million | -$0.24 | -$0.18 | -33.33% |
| 2011-12-31 | 2012-03-15 | $1.63 million | -$0.16 | -$0.20 | 20% |
| 2011-09-30 | 2011-11-07 | $2.64 million | -$0.16 | -$0.13 | -23.08% |
| 2011-06-30 | 2011-08-08 | $2.42 million | -$0.08 | -$0.19 | 57.89% |
| 2011-03-31 | 2011-05-11 | $3.11 million | -$0.08 | -$0.15 | 46.67% |
| 2010-12-31 | 2011-03-17 | $2.36 million | -$0.28 | -$0.15 | -86.67% |
| 2010-09-30 | 2010-11-15 | $1.28 million | -$0.04 | -$0.11 | 63.64% |
| 2010-06-30 | 2010-08-16 | $1.13 million | -$0.28 | -$0.08 | -250% |
| 2010-03-31 | 2010-05-17 | $1.37 million | -$0.08 | -$0.18 | 55.56% |
| 2009-12-31 | 2010-03-29 | $2.61 million | -$0.28 | -$0.16 | -75% |
| 2009-09-30 | 2009-11-16 | $3.65 million | -$0.12 | -$0.20 | 40% |
| 2009-06-30 | 2009-08-19 | $2.49 million | -$0.76 | -$0.24 | -216.67% |
| 2009-03-31 | 2009-05-15 | $369000 | -$0.31 | ||
| 2008-12-31 | 2009-03-31 | $327000 | -$0.32 | -$0.28 | -14.29% |
| 2008-09-30 | 2008-11-07 | $455000 | -$0.20 | -$0.38 | 47.37% |
| 2008-06-30 | 2008-08-07 | $663000 | -$0.36 | -$0.28 | -28.57% |
| 2008-03-31 | 2008-05-09 | $653000 | -$0.28 | -$0.44 | 36.36% |
| 2007-12-31 | 2008-03-17 | $3.32 million | -$0.08 | -$0.47 | 82.98% |
| 2007-09-30 | 2007-11-08 | $487000 | -$0.44 | -$0.39 | -12.82% |
| 2007-06-30 | 2007-08-08 | $495000 | -$0.44 | -$0.40 | -10% |
| 2007-03-31 | 2007-05-09 | $504000 | -$0.44 | -$0.37 | -18.92% |
| 2006-12-31 | 2007-03-16 | $1.53 million | -$0.56 | -$0.43 | -30.23% |
| 2006-09-30 | 2006-11-08 | $576000 | -$0.44 | -$0.40 | -10% |
| 2006-06-30 | 2006-08-08 | $663000 | -$0.40 | -$0.36 | -11.11% |
| 2006-03-31 | 2006-05-09 | $698000 | -$0.36 | -$0.44 | 18.18% |
| 2005-12-31 | 2006-03-16 | $829000 | -$2.40 | -$0.64 | -275% |
| 2005-09-30 | 2005-11-09 | $724000 | -$0.64 | -$0.86 | 25.58% |
| 2005-06-30 | 2005-08-09 | $2.95 million | -$0.44 | -$0.92 | 52.17% |
| 2005-03-31 | 2005-05-10 | $962000 | -$0.88 | -$0.88 | 0% |
| 2004-12-31 | 2005-03-15 | $543000 | -$0.84 | -$0.82 | -2.44% |
| 2004-09-30 | 2004-11-15 | $455000 | -$0.80 | -$0.52 | -53.85% |
| 2004-06-30 | 2004-08-09 | $100000 | -$0.13 | ||
| 2004-03-31 | 2004-05-15 | $69000 | -$0.40 | -$0.64 | 37.5% |
| 2003-12-31 | 2004-03-30 | $39000 | -$0.48 | -$0.48 | 0% |
| 2003-09-30 | 2003-11-12 | $22000 | -$2.46 | ||
| 2003-06-30 | 2003-07-16 | $9000 | -$0.44 | ||
| 2003-03-31 | 2003-03-31 | $11000 | -$1.23 |
Inovio Pharmaceuticals, Inc (INO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Inovio Pharmaceuticals, Inc (INO) Chart:
Inovio Pharmaceuticals, Inc (INO) News:
Below you will find a list of latest news for Inovio Pharmaceuticals, Inc (INO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Inovio Pharmaceuticals, Inc (INO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-08-29 | 0.5 | 1.42 | CALL | 0 | 6 | 542.38 | TRUE | 0 | 0 |
| 2025-08-29 | 1 | 0.5 | CALL | 0 | 8 | 566.93 | TRUE | 0 | 0 |
| 2025-08-29 | 1.5 | 0.35 | CALL | 2 | 224 | 360.89 | TRUE | 0 | 0 |
| 2025-08-29 | 2 | 0.09 | CALL | 21 | 64 | 112.19 | FALSE | 0.03 | 0.5 |
| 2025-08-29 | 2.5 | 0.08 | CALL | 0 | 14 | 147.27 | FALSE | 0 | 0 |
| 2025-08-29 | 3.5 | 0 | CALL | 0 | 0 | 261.31 | FALSE | 0 | 0 |
| 2025-08-29 | 4 | 0 | CALL | 0 | 0 | 484.68 | FALSE | 0 | 0 |
| 2025-08-29 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-08-29 | 1 | 0 | PUT | 0 | 0 | 886.25 | FALSE | 0 | 0 |
| 2025-08-29 | 1.5 | 0.05 | PUT | 1 | 12 | 188.68 | FALSE | 0.05 | 0 |
| 2025-08-29 | 2 | 0.13 | PUT | 0 | 26 | 154.01 | TRUE | 0 | 0 |
| 2025-08-29 | 2.5 | 0 | PUT | 0 | 0 | 301.55 | TRUE | 0 | 0 |
| 2025-08-29 | 3.5 | 0 | PUT | 0 | 0 | 569.75 | TRUE | 0 | 0 |
| 2025-08-29 | 4 | 0 | PUT | 0 | 0 | 575.65 | TRUE | 0 | 0 |
| 2025-09-05 | 0.5 | 1.64 | CALL | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2025-09-05 | 1 | 1.69 | CALL | 0 | 1 | 261.6 | TRUE | 0 | 0 |
| 2025-09-05 | 1.5 | 0 | CALL | 0 | 0 | 123.9 | TRUE | 0 | 0 |
| 2025-09-05 | 2 | 0.05 | CALL | 0 | 2 | 185.46 | FALSE | 0 | 0 |
| 2025-09-05 | 2.5 | 0 | CALL | 0 | 0 | 491.26 | FALSE | 0 | 0 |
| 2025-09-05 | 3 | 0 | CALL | 0 | 0 | 185.19 | FALSE | 0 | 0 |
| 2025-09-05 | 3.5 | 0 | CALL | 0 | 0 | 224.92 | FALSE | 0 | 0 |
| 2025-09-05 | 4 | 0 | CALL | 0 | 0 | 220.43 | FALSE | 0 | 0 |
| 2025-09-05 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-09-05 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-09-05 | 1.5 | 0 | PUT | 0 | 0 | 418.48 | FALSE | 0 | 0 |
| 2025-09-05 | 2 | 0 | PUT | 0 | 0 | 410.78 | TRUE | 0 | 0 |
| 2025-09-05 | 2.5 | 0 | PUT | 0 | 0 | 320.95 | TRUE | 0 | 0 |
| 2025-09-05 | 3 | 0 | PUT | 0 | 0 | 282.1 | TRUE | 0 | 0 |
| 2025-09-05 | 3.5 | 0 | PUT | 0 | 0 | 328.53 | TRUE | 0 | 0 |
| 2025-09-05 | 4 | 0 | PUT | 0 | 0 | 366.13 | TRUE | 0 | 0 |
| 2025-09-12 | 0.5 | 0 | CALL | 0 | 0 | 411.75 | TRUE | 0 | 0 |
| 2025-09-12 | 1 | 1.09 | CALL | 0 | 1 | 803.19 | TRUE | 0 | 0 |
| 2025-09-12 | 1.5 | 1.24 | CALL | 0 | 2 | 696.87 | TRUE | 0 | 0 |
| 2025-09-12 | 2 | 0.18 | CALL | 0 | 3 | 682.4 | FALSE | 0 | 0 |
| 2025-09-12 | 2.5 | 0 | CALL | 0 | 0 | 230.28 | FALSE | 0 | 0 |
| 2025-09-12 | 3.5 | 0 | CALL | 0 | 0 | 791.13 | FALSE | 0 | 0 |
| 2025-09-12 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-09-12 | 1 | 0 | PUT | 0 | 0 | 192.85 | FALSE | 0 | 0 |
| 2025-09-12 | 1.5 | 0 | PUT | 0 | 0 | 114.25 | FALSE | 0 | 0 |
| 2025-09-12 | 2 | 0 | PUT | 0 | 0 | 228.29 | TRUE | 0 | 0 |
| 2025-09-12 | 2.5 | 0 | PUT | 0 | 0 | 386.63 | TRUE | 0 | 0 |
| 2025-09-12 | 3.5 | 0 | PUT | 0 | 0 | 359.62 | TRUE | 0 | 0 |
| 2025-09-19 | 0.5 | 0 | CALL | 0 | 0 | 645.68 | TRUE | 0 | 0 |
| 2025-09-19 | 1 | 0.93 | CALL | 0 | 5 | 342.63 | TRUE | 0 | 0 |
| 2025-09-19 | 1.5 | 0 | CALL | 0 | 0 | 432.02 | TRUE | 0 | 0 |
| 2025-09-19 | 2 | 0.16 | CALL | 0 | 302 | 62.79 | FALSE | 0 | 0 |
| 2025-09-19 | 2.5 | 0 | CALL | 0 | 0 | 111.24 | FALSE | 0 | 0 |
| 2025-09-19 | 3 | 0 | CALL | 0 | 0 | 150.69 | FALSE | 0 | 0 |
| 2025-09-19 | 3.5 | 0 | CALL | 0 | 0 | 161.46 | FALSE | 0 | 0 |
| 2025-09-19 | 4 | 0 | CALL | 0 | 0 | 184.74 | FALSE | 0 | 0 |
| 2025-09-19 | 5 | 0 | CALL | 0 | 0 | 221.3 | FALSE | 0 | 0 |
| 2025-09-19 | 0.5 | 0 | PUT | 0 | 0 | 1059.67 | FALSE | 0 | 0 |
| 2025-09-19 | 1 | 0.04 | PUT | 0 | 2 | 204.21 | FALSE | 0 | 0 |
| 2025-09-19 | 1.5 | 0 | PUT | 0 | 0 | 166.78 | FALSE | 0 | 0 |
| 2025-09-19 | 2 | 0.28 | PUT | 0 | 27 | 93.77 | TRUE | 0 | 0 |
| 2025-09-19 | 2.5 | 0 | PUT | 0 | 0 | 208.58 | TRUE | 0 | 0 |
| 2025-09-19 | 3 | 1.3 | PUT | 0 | 6 | 230.16 | TRUE | 0 | 0 |
| 2025-09-19 | 3.5 | 0 | PUT | 0 | 0 | 264.79 | TRUE | 0 | 0 |
| 2025-09-19 | 4 | 0 | PUT | 0 | 0 | 318.39 | TRUE | 0 | 0 |
| 2025-09-19 | 5 | 0 | PUT | 0 | 0 | 375.61 | TRUE | 0 | 0 |
| 2025-09-26 | 0.5 | 1.96 | CALL | 0 | 2 | 804.46 | TRUE | 0 | 0 |
| 2025-09-26 | 1 | 0 | CALL | 0 | 0 | 627.43 | TRUE | 0 | 0 |
| 2025-09-26 | 1.5 | 0 | CALL | 0 | 0 | 561.73 | TRUE | 0 | 0 |
| 2025-09-26 | 2 | 0 | CALL | 0 | 0 | 463.54 | FALSE | 0 | 0 |
| 2025-09-26 | 2.5 | 0.07 | CALL | 0 | 1 | 99.64 | FALSE | 0 | 0 |
| 2025-09-26 | 3.5 | 0 | CALL | 0 | 0 | 618.13 | FALSE | 0 | 0 |
| 2025-09-26 | 0.5 | 0.36 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2025-09-26 | 1 | 0 | PUT | 0 | 0 | 1150.12 | FALSE | 0 | 0 |
| 2025-09-26 | 1.5 | 0 | PUT | 0 | 0 | 733.87 | FALSE | 0 | 0 |
| 2025-09-26 | 2 | 0 | PUT | 0 | 0 | 179.3 | TRUE | 0 | 0 |
| 2025-09-26 | 2.5 | 0 | PUT | 0 | 0 | 437.16 | TRUE | 0 | 0 |
| 2025-09-26 | 3.5 | 0 | PUT | 0 | 0 | 282.91 | TRUE | 0 | 0 |
| 2025-10-03 | 0.5 | 0 | CALL | 0 | 0 | 786.07 | TRUE | 0 | 0 |
| 2025-10-03 | 1 | 0 | CALL | 0 | 0 | 573.89 | TRUE | 0 | 0 |
| 2025-10-03 | 1.5 | 0 | CALL | 0 | 0 | 497.86 | TRUE | 0 | 0 |
| 2025-10-03 | 2 | 0 | CALL | 0 | 0 | 500.99 | FALSE | 0 | 0 |
| 2025-10-03 | 2.5 | 0 | CALL | 0 | 0 | 518.41 | FALSE | 0 | 0 |
| 2025-10-03 | 3 | 0 | CALL | 0 | 0 | 551.32 | FALSE | 0 | 0 |
| 2025-10-03 | 3.5 | 0 | CALL | 0 | 0 | 565.44 | FALSE | 0 | 0 |
| 2025-10-03 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-10-03 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-10-03 | 1.5 | 0 | PUT | 0 | 0 | 631.6 | FALSE | 0 | 0 |
| 2025-10-03 | 2 | 0 | PUT | 0 | 0 | 397.13 | TRUE | 0 | 0 |
| 2025-10-03 | 2.5 | 0 | PUT | 0 | 0 | 400.6 | TRUE | 0 | 0 |
| 2025-10-03 | 3 | 0 | PUT | 0 | 0 | 306.92 | TRUE | 0 | 0 |
| 2025-10-03 | 3.5 | 0 | PUT | 0 | 0 | 259.63 | TRUE | 0 | 0 |
| 2025-10-17 | 1 | 0.85 | CALL | 0 | 4 | 323.3 | TRUE | 0 | 0 |
| 2025-10-17 | 2 | 0.25 | CALL | 3 | 30 | 93.82 | FALSE | 0.25 | 0 |
| 2025-10-17 | 3 | 0 | CALL | 0 | 0 | 106.97 | FALSE | 0 | 0 |
| 2025-10-17 | 4 | 0 | CALL | 0 | 0 | 262.59 | FALSE | 0 | 0 |
| 2025-10-17 | 5 | 0 | CALL | 0 | 0 | 539.61 | FALSE | 0 | 0 |
| 2025-10-17 | 1 | 0 | PUT | 0 | 0 | 366.62 | FALSE | 0 | 0 |
| 2025-10-17 | 2 | 0.38 | PUT | 0 | 1 | 68.07 | TRUE | 0 | 0 |
| 2025-10-17 | 3 | 0 | PUT | 0 | 0 | 166.54 | TRUE | 0 | 0 |
| 2025-10-17 | 4 | 0 | PUT | 0 | 0 | 212.2 | TRUE | 0 | 0 |
| 2025-10-17 | 5 | 0 | PUT | 0 | 0 | 314.93 | TRUE | 0 | 0 |
| 2025-11-21 | 1 | 0.94 | CALL | 0 | 237 | 135.01 | TRUE | 0 | 0 |
| 2025-11-21 | 2 | 0.25 | CALL | 22 | 6583 | 73.05 | FALSE | 0 | 0 |
| 2025-11-21 | 3 | 0.1 | CALL | 10 | 1456 | 92.58 | FALSE | 0.03 | 0.43 |
| 2025-11-21 | 4 | 0.02 | CALL | 0 | 472 | 114.49 | FALSE | 0 | 0 |
| 2025-11-21 | 5 | 0.05 | CALL | 0 | 365 | 107.26 | FALSE | 0 | 0 |
| 2025-11-21 | 1 | 0.05 | PUT | 0 | 31 | 132.28 | FALSE | 0 | 0 |
| 2025-11-21 | 2 | 0.4 | PUT | 0 | 116 | 48.03 | TRUE | 0 | 0 |
| 2025-11-21 | 3 | 1.65 | PUT | 0 | 8 | 103.72 | TRUE | 0 | 0 |
| 2025-11-21 | 4 | 0 | PUT | 0 | 0 | 169.75 | TRUE | 0 | 0 |
| 2025-11-21 | 5 | 0 | PUT | 0 | 0 | 195.76 | TRUE | 0 | 0 |
| 2026-02-20 | 1 | 0.95 | CALL | 47 | 1656 | 64.44 | TRUE | -0.03 | -0.03 |
| 2026-02-20 | 2 | 0.36 | CALL | 48 | 2427 | 71.02 | FALSE | -0.04 | -0.1 |
| 2026-02-20 | 3 | 0.19 | CALL | 13 | 1183 | 84.33 | FALSE | -0.01 | -0.05 |
| 2026-02-20 | 4 | 0.12 | CALL | 0 | 490 | 87.5 | FALSE | 0 | 0 |
| 2026-02-20 | 5 | 0.05 | CALL | 0 | 37 | 110.08 | FALSE | 0 | 0 |
| 2026-02-20 | 1 | 0.08 | PUT | 0 | 54 | 105.48 | FALSE | 0 | 0 |
| 2026-02-20 | 2 | 0.55 | PUT | 1 | 291 | 97.15 | TRUE | 0.55 | 0 |
| 2026-02-20 | 3 | 1.1 | PUT | 0 | 19 | 82.43 | TRUE | 0 | 0 |
| 2026-02-20 | 4 | 2.69 | PUT | 0 | 1 | 71.39 | TRUE | 0 | 0 |
| 2026-02-20 | 5 | 0 | PUT | 0 | 0 | 88.13 | TRUE | 0 | 0 |
Latest INO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 500 | $1.47 |
| Jun 13, 2022 7:59 PM EST | 5 | $1.47 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.465 |
| Jun 13, 2022 7:59 PM EST | 500 | $1.47 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.47 |
Inovio Pharmaceuticals, Inc (INO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/0001055726-20-000043-index.htm |
| 2018-06-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1055726/000000000018017637/0000000000-18-017637-index.htm |
| 2020-02-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1055726/000000000020001261/0000000000-20-001261-index.htm |
| 2020-03-23 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1055726/000000000020002492/0000000000-20-002492-index.htm |
| 2020-04-14 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1055726/000000000020003215/0000000000-20-003215-index.htm |
| 2020-05-01 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1055726/000000000020003771/0000000000-20-003771-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1055726/000021545719004059/0000215457-19-004059-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1055726/000081413319000020/0000814133-19-000020-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1055726/000081413320000032/0000814133-20-000032-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1055726/000083423720005356/0000834237-20-005356-index.htm |
| 2018-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000021/0001055726-18-000021-index.htm |
| 2018-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm |
| 2018-04-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000023/0001055726-18-000023-index.htm |
| 2018-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000026/0001055726-18-000026-index.htm |
| 2018-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000027/0001055726-18-000027-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/0001055726-18-000028-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000029/0001055726-18-000029-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000030/0001055726-18-000030-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000031/0001055726-18-000031-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000032/0001055726-18-000032-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000033/0001055726-18-000033-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000034/0001055726-18-000034-index.htm |
| 2018-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000040/0001055726-18-000040-index.htm |
| 2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/0001055726-18-000042-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000045/0001055726-18-000045-index.htm |
| 2018-11-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000047/0001055726-18-000047-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000048/0001055726-18-000048-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000049/0001055726-18-000049-index.htm |
| 2019-01-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000003/0001055726-19-000003-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000004/0001055726-19-000004-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000006/0001055726-19-000006-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000007/0001055726-19-000007-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000008/0001055726-19-000008-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000009/0001055726-19-000009-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000012/0001055726-19-000012-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000014/0001055726-19-000014-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/0001055726-19-000015-index.htm |
| 2019-03-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000017/0001055726-19-000017-index.htm |
| 2019-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/0001055726-19-000018-index.htm |
| 2019-03-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000021/0001055726-19-000021-index.htm |
| 2019-03-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000022/0001055726-19-000022-index.htm |
| 2019-03-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000023/0001055726-19-000023-index.htm |
| 2019-03-27 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000024/0001055726-19-000024-index.htm |
| 2019-03-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000025/0001055726-19-000025-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000029/0001055726-19-000029-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000030/0001055726-19-000030-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000031/0001055726-19-000031-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000032/0001055726-19-000032-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000033/0001055726-19-000033-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000034/0001055726-19-000034-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000035/0001055726-19-000035-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000036/0001055726-19-000036-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000037/0001055726-19-000037-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000038/0001055726-19-000038-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000039/0001055726-19-000039-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000040/0001055726-19-000040-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000041/0001055726-19-000041-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/0001055726-19-000042-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000044/0001055726-19-000044-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000047/0001055726-19-000047-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000049/0001055726-19-000049-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000052/0001055726-19-000052-index.htm |
| 2019-08-15 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000054/0001055726-19-000054-index.htm |
| 2019-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000056/0001055726-19-000056-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000058/0001055726-19-000058-index.htm |
| 2019-12-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000059/0001055726-19-000059-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000001/0001055726-20-000001-index.htm |
| 2020-01-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000002/0001055726-20-000002-index.htm |
| 2020-01-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000003/0001055726-20-000003-index.htm |
| 2020-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000004/0001055726-20-000004-index.htm |
| 2020-01-24 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000005/0001055726-20-000005-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/0001055726-20-000006-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/0001055726-20-000007-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/0001055726-20-000008-index.htm |
| 2020-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000012/0001055726-20-000012-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/0001055726-20-000014-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/0001055726-20-000015-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000016/0001055726-20-000016-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/0001055726-20-000017-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000018/0001055726-20-000018-index.htm |
| 2020-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000019/0001055726-20-000019-index.htm |
| 2020-03-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000022/0001055726-20-000022-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000024/0001055726-20-000024-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000025/0001055726-20-000025-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000026/0001055726-20-000026-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000027/0001055726-20-000027-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000028/0001055726-20-000028-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000029/0001055726-20-000029-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000032/0001055726-20-000032-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000033/0001055726-20-000033-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000034/0001055726-20-000034-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000035/0001055726-20-000035-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000036/0001055726-20-000036-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000037/0001055726-20-000037-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000038/0001055726-20-000038-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000039/0001055726-20-000039-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000040/0001055726-20-000040-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000042/0001055726-20-000042-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/0001055726-20-000043-index.htm |
| 2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/0001055726-20-000044-index.htm |
| 2020-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000045/0001055726-20-000045-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000048/0001055726-20-000048-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000049/0001055726-20-000049-index.htm |
| 2020-02-11 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1055726/000110465920016487/0001104659-20-016487-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1055726/000114036120002954/0001140361-20-002954-index.htm |
| 2018-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312518162187/0001193125-18-162187-index.htm |
| 2018-05-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312518175305/0001193125-18-175305-index.htm |
| 2018-05-25 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1055726/000119312518175375/0001193125-18-175375-index.htm |
| 2018-06-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1055726/000119312518185845/0001193125-18-185845-index.htm |
| 2018-06-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1055726/000119312518189390/0001193125-18-189390-index.htm |
| 2019-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519001663/0001193125-19-001663-index.htm |
| 2019-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519037998/0001193125-19-037998-index.htm |
| 2019-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519045422/0001193125-19-045422-index.htm |
| 2019-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519051968/0001193125-19-051968-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519071917/0001193125-19-071917-index.htm |
| 2019-03-15 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1055726/000119312519076809/0001193125-19-076809-index.htm |
| 2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519085283/0001193125-19-085283-index.htm |
| 2019-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519144262/0001193125-19-144262-index.htm |
| 2019-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519152325/0001193125-19-152325-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519158298/0001193125-19-158298-index.htm |
| 2019-05-31 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1055726/000119312519162877/0001193125-19-162877-index.htm |
| 2019-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519164685/0001193125-19-164685-index.htm |
| 2019-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519194826/0001193125-19-194826-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312519214088/0001193125-19-214088-index.htm |
| 2020-01-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520000651/0001193125-20-000651-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520008085/0001193125-20-008085-index.htm |
| 2020-01-31 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1055726/000119312520021426/0001193125-20-021426-index.htm |
| 2020-01-31 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1055726/000119312520021435/0001193125-20-021435-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520028310/0001193125-20-028310-index.htm |
| 2020-02-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1055726/000119312520028334/0001193125-20-028334-index.htm |
| 2020-02-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1055726/000119312520029793/0001193125-20-029793-index.htm |
| 2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520065842/0001193125-20-065842-index.htm |
| 2020-03-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1055726/000119312520065907/0001193125-20-065907-index.htm |
| 2020-03-13 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1055726/000119312520072995/0001193125-20-072995-index.htm |
| 2020-03-27 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1055726/000119312520088806/0001193125-20-088806-index.htm |
| 2020-04-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1055726/000119312520098301/0001193125-20-098301-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520098305/0001193125-20-098305-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520099003/0001193125-20-099003-index.htm |
| 2020-04-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1055726/000119312520108190/0001193125-20-108190-index.htm |
| 2020-04-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1055726/000119312520119137/0001193125-20-119137-index.htm |
| 2020-05-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1055726/000119312520140456/0001193125-20-140456-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520140512/0001193125-20-140512-index.htm |
| 2020-05-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520145017/0001193125-20-145017-index.htm |
| 2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520159486/0001193125-20-159486-index.htm |
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520179128/0001193125-20-179128-index.htm |
| 2020-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520239111/0001193125-20-239111-index.htm |
| 2020-09-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520256781/0001193125-20-256781-index.htm |
| 2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1055726/000119312520270257/0001193125-20-270257-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1055726/000121465920001194/0001214659-20-001194-index.htm |
| 2018-06-08 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1055726/999999999518001464/9999999995-18-001464-index.htm |
| 2020-02-13 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1055726/999999999520000352/9999999995-20-000352-index.htm |
| 2020-03-31 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1055726/999999999520000654/9999999995-20-000654-index.htm |
Inovio Pharmaceuticals, Inc (INO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inovio Pharmaceuticals, Inc (INO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 217%Institutional Ownership: 3649%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-03-09 | PETER KIES | CFO | Buy | 25,000.00 | 104,354.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000014/0001055726-19-000014-index.htm | ||
| 2018-12-06 | AVTAR S DHILLON | Director | Buy | 25,000.00 | 2.00 | 50,000.00 | 106,002.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000049/0001055726-18-000049-index.htm |
| 2019-06-03 | Jong Joseph Kim | Chief Executive Officer | Sell | 832,848.00 | 2.30 | 1,914,467.70 | 1,078,207.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm |
| 2019-03-05 | Mark Bagarazzi | Chief Medical Officer | Buy | 27,567.00 | 109,080.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000009/0001055726-19-000009-index.htm | ||
| 2020-01-13 | Jong Joseph Kim | Chief Executive Officer | Buy | 22,500.00 | 3.11 | 69,975.00 | 1,100,707.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000002/0001055726-20-000002-index.htm |
| 2019-05-31 | Jong Joseph Kim | Chief Executive Officer | Sell | 500,000.00 | 2.40 | 1,200,800.00 | 1,113,232.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm |
| 2019-03-10 | PETER KIES | CFO | Buy | 20,433.00 | 116,196.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000014/0001055726-19-000014-index.htm | ||
| 2020-07-30 | Jong Joseph Kim | Chief Executive Officer | Sell | 100,000.00 | 21.13 | 2,113,450.00 | 1,188,313.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000045/0001055726-20-000045-index.htm |
| 2020-06-30 | PETER KIES | CFO | Sell | 35,000.00 | 26.50 | 927,500.00 | 119,290.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/0001055726-20-000043-index.htm |
| 2020-07-15 | PETER KIES | CFO | Sell | 35,000.00 | 24.95 | 873,208.00 | 119,290.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/0001055726-20-000044-index.htm |
| 2020-05-08 | Lota S. Zoth | Director | Buy | 8,013.00 | 12,103.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000028/0001055726-20-000028-index.htm | ||
| 2020-03-05 | Jong Joseph Kim | Chief Executive Officer | Buy | 120,100.00 | 1,220,807.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/0001055726-20-000008-index.htm | ||
| 2019-05-11 | WENDY L YARNO | Director | Buy | 8,170.00 | 12,260.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000041/0001055726-19-000041-index.htm | ||
| 2020-05-08 | Ann Calby Miller | Director | Buy | 8,013.00 | 12,287.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000025/0001055726-20-000025-index.htm | ||
| 2020-03-08 | Jong Joseph Kim | Chief Executive Officer | Buy | 63,700.00 | 1,247,136.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/0001055726-20-000008-index.htm | ||
| 2020-03-10 | Jong Joseph Kim | Chief Executive Officer | Buy | 105,700.00 | 1,325,139.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/0001055726-20-000017-index.htm | ||
| 2020-03-05 | PETER KIES | CFO | Buy | 27,567.00 | 136,697.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/0001055726-20-000006-index.htm | ||
| 2020-03-08 | PETER KIES | CFO | Buy | 21,467.00 | 148,347.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/0001055726-20-000006-index.htm | ||
| 2020-07-15 | PETER KIES | CFO | Buy | 35,000.00 | 2.40 | 84,000.00 | 154,290.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/0001055726-20-000044-index.htm |
| 2018-05-12 | MORTON COLLINS | Director | Buy | 7,669.00 | 159,960.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000030/0001055726-18-000030-index.htm | ||
| 2019-05-16 | Jong Joseph Kim | Chief Executive Officer | Sell | 61,212.00 | 3.50 | 214,242.00 | 1,613,232.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/0001055726-19-000042-index.htm |
| 2020-03-10 | PETER KIES | CFO | Buy | 20,433.00 | 161,356.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/0001055726-20-000014-index.htm | ||
| 2019-12-05 | WENDY L YARNO | Director | Buy | 4,090.00 | 16,350.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000059/0001055726-19-000059-index.htm | ||
| 2020-03-25 | Jacqueline Elizabeth Shea | Chief Operating Officer | Buy | 16,667.00 | 16,667.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000019/0001055726-20-000019-index.htm | ||
| 2019-05-15 | Jong Joseph Kim | Chief Executive Officer | Sell | 75,556.00 | 3.50 | 264,446.00 | 1,674,444.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/0001055726-19-000042-index.htm |
| 2019-05-11 | MORTON COLLINS | Director | Buy | 8,170.00 | 168,130.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000037/0001055726-19-000037-index.htm | ||
| 2019-05-31 | Jong Joseph Kim | Chief Executive Officer | Sell | 500,000.00 | 2.44 | 1,217,650.00 | 1,911,055.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm |
| 2018-05-12 | ADEL MAHMOUD | Director | Buy | 7,669.00 | 22,669.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000032/0001055726-18-000032-index.htm | ||
| 2018-04-12 | Jong Joseph Kim | Chief Executive Officer | Sell | 103,750.00 | 5.14 | 533,140.13 | 2,291,807.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm |
| 2018-04-13 | Jong Joseph Kim | Chief Executive Officer | Sell | 107,500.00 | 5.06 | 543,412.50 | 2,291,807.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm |
| 2018-09-12 | Jong Joseph Kim | Chief Executive Officer | Sell | 49,060.00 | 5.37 | 263,452.20 | 2,308,494.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/0001055726-18-000042-index.htm |
| 2018-05-08 | Jong Joseph Kim | Chief Executive Officer | Buy | 23,333.00 | 2,315,140.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000027/0001055726-18-000027-index.htm | ||
| 2018-09-12 | Jong Joseph Kim | Chief Executive Officer | Buy | 49,060.00 | 5.08 | 249,224.80 | 2,357,554.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/0001055726-18-000042-index.htm |
| 2018-04-12 | Jong Joseph Kim | Chief Executive Officer | Buy | 103,750.00 | 2.40 | 249,000.00 | 2,395,557.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm |
| 2018-04-13 | Jong Joseph Kim | Chief Executive Officer | Buy | 107,500.00 | 2.16 | 232,200.00 | 2,399,307.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm |
| 2019-05-21 | Jong Joseph Kim | Chief Executive Officer | Sell | 100,000.00 | 3.31 | 331,000.00 | 2,411,055.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000044/0001055726-19-000044-index.htm |
| 2019-03-05 | Jong Joseph Kim | Chief Executive Officer | Buy | 120,100.00 | 2,428,594.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000007/0001055726-19-000007-index.htm | ||
| 2020-05-08 | WENDY L YARNO | Director | Buy | 8,013.00 | 24,363.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000027/0001055726-20-000027-index.htm | ||
| 2019-03-09 | Jong Joseph Kim | Chief Executive Officer | Buy | 57,333.00 | 2,451,788.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/0001055726-19-000015-index.htm | ||
| 2019-03-09 | Laurent Humeau | Chief Scientific Officer | Buy | 2,666.00 | 24,867.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/0001055726-19-000018-index.htm | ||
| 2019-03-10 | Jong Joseph Kim | Chief Executive Officer | Buy | 105,700.00 | 2,541,159.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/0001055726-19-000015-index.htm | ||
| 2019-03-10 | Laurent Humeau | Chief Scientific Officer | Buy | 2,812.00 | 26,781.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/0001055726-19-000018-index.htm | ||
| 2018-04-12 | SIMON X BENITO | Director | Sell | 3,750.00 | 5.23 | 19,618.88 | 27,798.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000021/0001055726-18-000021-index.htm |
| 2018-04-12 | SIMON X BENITO | Director | Buy | 3,750.00 | 3.56 | 13,350.00 | 31,548.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000021/0001055726-18-000021-index.htm |
| 2018-05-12 | SIMON X BENITO | Director | Buy | 7,669.00 | 35,467.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000029/0001055726-18-000029-index.htm | ||
| 2020-01-03 | Lota S. Zoth | Director | Buy | 4,090.00 | 4,090.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000001/0001055726-20-000001-index.htm | ||
| 2018-12-05 | WENDY L YARNO | Director | Buy | 4,090.00 | 4,090.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000048/0001055726-18-000048-index.htm | ||
| 2020-03-21 | Ann Calby Miller | Director | Buy | 4,274.00 | 4,274.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000018/0001055726-20-000018-index.htm | ||
| 2019-05-11 | SIMON X BENITO | Director | Buy | 8,170.00 | 43,637.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000040/0001055726-19-000040-index.htm | ||
| 2020-08-10 | Laurent Humeau | Chief Scientific Officer | Sell | 19,467.00 | 19.06 | 371,004.03 | 43,966.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000049/0001055726-20-000049-index.htm |
| 2019-06-05 | Laurent Humeau | Chief Scientific Officer | Buy | 20,000.00 | 2.50 | 50,000.00 | 45,833.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000047/0001055726-19-000047-index.htm |
| 2019-08-30 | Laurent Humeau | Chief Scientific Officer | Buy | 4,500.00 | 2.22 | 9,990.00 | 50,333.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000056/0001055726-19-000056-index.htm |
| 2020-05-08 | SIMON X BENITO | Director | Buy | 8,013.00 | 51,650.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000029/0001055726-20-000029-index.htm | ||
| 2020-05-20 | SIMON X BENITO | Director | Sell | 8,750.00 | 15.95 | 139,594.00 | 51,650.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000040/0001055726-20-000040-index.htm |
| 2018-05-12 | Angel Cabrera | Director | Buy | 7,669.00 | 59,419.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000033/0001055726-18-000033-index.htm | ||
| 2020-05-20 | SIMON X BENITO | Director | Buy | 8,750.00 | 4.60 | 40,250.00 | 60,400.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000040/0001055726-20-000040-index.htm |
| 2018-07-10 | PETER KIES | CFO | Sell | 10,000.00 | 4.45 | 44,500.00 | 62,088.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm |
| 2018-11-29 | PETER KIES | CFO | Sell | 10,001.00 | 5.28 | 52,805.28 | 62,088.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000047/0001055726-18-000047-index.htm |
| 2020-06-22 | Laurent Humeau | Chief Scientific Officer | Sell | 19,467.00 | 14.70 | 286,164.90 | 63,433.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000042/0001055726-20-000042-index.htm |
| 2019-05-11 | Angel Cabrera | Director | Buy | 8,170.00 | 67,589.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000039/0001055726-19-000039-index.htm | ||
| 2018-07-09 | PETER KIES | CFO | Sell | 25,000.00 | 4.43 | 110,750.00 | 72,088.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm |
| 2018-11-29 | PETER KIES | CFO | Buy | 10,001.00 | 2.00 | 20,002.00 | 72,089.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000047/0001055726-18-000047-index.htm |
| 2020-05-08 | Angel Cabrera | Director | Buy | 8,013.00 | 75,602.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000024/0001055726-20-000024-index.htm | ||
| 2018-04-16 | David B. Weiner | Director | Sell | 9,000.00 | 4.91 | 44,202.60 | 758,956.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000023/0001055726-18-000023-index.htm |
| 2018-05-12 | David B. Weiner | Director | Buy | 7,669.00 | 766,625.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000034/0001055726-18-000034-index.htm | ||
| 2019-03-05 | David B. Weiner | Director | Buy | 11,667.00 | 778,292.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000008/0001055726-19-000008-index.htm | ||
| 2020-03-05 | Laurent Humeau | Chief Scientific Officer | Buy | 27,567.00 | 77,900.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/0001055726-20-000007-index.htm | ||
| 2019-03-09 | David B. Weiner | Director | Buy | 5,333.00 | 783,625.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm | ||
| 2019-03-09 | David B. Weiner | Director | Buy | 10,000.00 | 793,625.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm | ||
| 2019-08-01 | David B. Weiner | Director | Sell | 16,352.00 | 2.72 | 44,477.44 | 797,110.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000049/0001055726-19-000049-index.htm |
| 2019-03-10 | David B. Weiner | Director | Buy | 11,667.00 | 805,292.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm | ||
| 2020-03-05 | David B. Weiner | Director | Buy | 11,667.00 | 808,777.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm | ||
| 2018-05-12 | AVTAR S DHILLON | Director | Buy | 7,669.00 | 81,002.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/0001055726-18-000028-index.htm | ||
| 2019-05-11 | David B. Weiner | Director | Buy | 8,170.00 | 813,462.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000038/0001055726-19-000038-index.htm | ||
| 2019-06-03 | Jong Joseph Kim | Chief Executive Officer | Sell | 296,705.00 | 2.31 | 684,735.80 | 816,527.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm |
| 2020-03-09 | David B. Weiner | Director | Sell | 3,500.00 | 18.00 | 63,000.00 | 816,944.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm |
| 2020-03-08 | David B. Weiner | Director | Buy | 11,667.00 | 820,444.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm | ||
| 2020-03-12 | David B. Weiner | Director | Sell | 3,500.00 | 11.14 | 38,990.00 | 821,610.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm |
| 2020-03-10 | David B. Weiner | Director | Sell | 3,500.00 | 9.32 | 32,620.00 | 825,110.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm |
| 2020-05-11 | David B. Weiner | Director | Sell | 2,404.00 | 11.84 | 28,463.36 | 827,219.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000033/0001055726-20-000033-index.htm |
| 2020-03-10 | David B. Weiner | Director | Buy | 11,666.00 | 828,610.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm | ||
| 2020-05-08 | David B. Weiner | Director | Buy | 8,013.00 | 829,623.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000026/0001055726-20-000026-index.htm | ||
| 2020-03-10 | Laurent Humeau | Chief Scientific Officer | Buy | 2,812.00 | 83,873.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/0001055726-20-000015-index.htm | ||
| 2020-03-08 | Laurent Humeau | Chief Scientific Officer | Buy | 19,900.00 | 87,943.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/0001055726-20-000007-index.htm | ||
| 2019-03-05 | PETER KIES | CFO | Buy | 27,567.00 | 89,655.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572619000006/0001055726-19-000006-index.htm | ||
| 2018-07-09 | PETER KIES | CFO | Buy | 15,000.00 | 4.24 | 63,600.00 | 97,088.00 | https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm |